Mylan Laboratories Inc. has received approval from the U.S. Food and Drug Administration for the generic, tablet form of Pfizer's Accuretic blood-pressure medication, the company said Friday... The Canonsburg, Pa.-based generic drugmaker (NYSE:MYL) said the FDA gave the go-ahead on its abbreviated new drug application for quinapril hydrochloride and hydrochlorothiazide tablets, in 10-, 12.5- 20- and 25-milligram tablets...